Skip to main content
OpenTrials
Completed

NCT Number: NCT02146716

Assessment of Energetic Resonance by Cutaneous Stimulation on Withdrawal Alcohol Symptoms.

The purpose of RESC study is to assess the efficacy of Energetic Resonance by Cutaneous Stimulation on alcohol withdrawal symptoms measured by CUSHMAN score and in a second time to measure the benzodiazepine amount prescribed during the withdrawal time.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Alcohol Withdrawal Syndrome

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hôpital croix rousse

Lyon, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women between 18 and 80 years,
  • Patient with alcohol addiction,
  • Patient needing alcohol withdrawal in a hospital.
  • Patient with social Security,
  • Patient with inform consent signed.

Exclusion criteria

  • Pregnant women
  • Minor.
  • Major with guardianship.
  • People without sufficient information because of troubles of cognitive functions, or without sufficient knowledge of French language.

Treatment and study plan

Energetic Resonance by Cutaneous Stimulation

Other

Energetic Resonance by Cutaneous Stimulation (RESC) is a non-invasive method based on energetic Chinese medicine principles and digital contact. RESC is characterized by echo phenomena between two stimulation points.

Primary outcomes

  1. Cushman Score measure after Energetic Resonance by Cutaneous Stimulation

    Time frame: daily during one week

    CUSHMAN score is represented by a scale with 7 variables collecting physiological modifications or behavioural manifestations related to adrenergic answer, neurovegetative signs, confusion, nervousness, perceptive or hallucinatory phenomena.

Secondary outcomes

  1. Anxiety depression scale

    Time frame: pre-screening, day 3 and day 7

  2. prescribed benzodiazepine amount

    Time frame: day 0 to day 7

  3. Analogic Visual Scale

    Time frame: before and after each Energetic Resonance by Cutaneous Stimulationsession at day 2, day 4 and day 6.

  4. Quality of life scale

    Time frame: day 0

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Acronym: RESC

Important dates

Study start
2014
Primary completion
2016
Study completion
2017
First posted
May 26, 2014
Registry last updated
Aug 23, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.